Skip to main content
  • Clinical Trials
Menu
Home
SPR
  • Healthcare Professionals
    • SPRINT® PNS System
      • Overview
      • Product Details
    • Clinical Evidence
    • Video Resources
    • Reimbursement
    • Education
    • Safety Information
    • MRI Safety Information
  • Patients & Caregivers
    • SPRINT® PNS System
      • Why SPRINT?
      • How It Works
      • What To Expect
      • Helpful FAQs
      • Safety Information
      • MRI Safety Information
    • Resources
      • Overview
      • Instructional Videos
      • Patient Stories
      • Recursos para pacientes
      • Clinical Evidence
  • About Us
    • About SPR
    • Leadership
    • Company Credo
  • News
  • Events
  • Careers
    • Overview
    • Job Listing
  • Contact Us

News

Breadcrumb

  1. Home
  2. News

All News

▼
common pain syndromes blog post image common pain syndromes blog post image

Some of the most common pain syndromes and how SPRINT PNS can help

Patient Education
APPs role in pain therapy thumbnail APPs role in pain therapy thumbnail

Advanced practice providers play a pivotal role in pain therapy

Perspectives from Health Care Professionals
Dr. Shalini Shah thumbnail 2020 Dr. Shalini Shah thumbnail 2020

Pelvic pain in women: Talking stigma and treatment options with Dr. Shalini Shah

Perspectives from Health Care Professionals
study of post-amputation pain blog post thumbnail study of post-amputation pain blog post thumbnail

Study demonstrates 12-month relief of post-amputation pain following treatment with SPRINT PNS System

Data + Publications Press Releases + Media Research
SPR revolutionizes pain relief 2019 blog post thumbnail SPR revolutionizes pain relief 2019 blog post thumbnail

SPR revolutionizes pain relief amidst opioid crisis

Data + Publications Research
SPRINT PNS may provide significant pain relief blog post thumbnail SPRINT PNS may provide significant pain relief blog post thumbnail

Peripheral nerve stimulation system may provide significant pain relief

Data + Publications Research
NIH funding thumbnail NIH funding thumbnail

SPR awarded $1.45M grant from National Institutes of Health to develop implantable pain management system

Company News
CE mark thumbnail CE mark thumbnail

SPR receives CE mark for Smartpatch PNS System

Company News
$5 million series A thumbnail $5 million series A thumbnail

SPR raises $5 million Series A

Company News

Pagination

  • Previous page ‹
  • Page1
  • Page2
  • Current page3
  • Healthcare Professionals
    • SPRINT® PNS System
      • Overview
      • Product Details
    • Clinical Evidence
    • Video Resources
    • Reimbursement
    • Education
    • Safety Information
    • MRI Safety Information
  • Patients & Caregivers
    • SPRINT® PNS System
      • Why SPRINT?
      • How It Works
      • What To Expect
      • Helpful FAQs
      • Safety Information
      • MRI Safety Information
    • Resources
      • Overview
      • Instructional Videos
      • Patient Stories
      • Recursos para pacientes
      • Clinical Evidence
  • About Us
    • About SPR
    • Leadership
    • Company Credo
  • News
  • Events
  • Careers
    • Overview
    • Job Listing
  • Contact Us
  • CPRA Requests
  • Consumer Health Data Request Form
  • Compliance
  • FCOI Policy
  • MRI Safety Information
  • Patent Information
  • Product Terms and Conditions
  • Safety Information
  • Trademarks
  • Billing Portal
Home
  • Consumer Health Data and Information Privacy Policy
  • Terms of Use
Visit us on Facebook
Visit us on Twitter
Visit us on Instagram
Visit us on YouTube
Visit us on LinkedIn

The SPRINT PNS System is indicated for up to 60 days for: (i) Symptomatic relief of chronic, intractable pain, post-surgical and post-traumatic acute pain; (ii) Symptomatic relief of post-traumatic pain; and (iii) Symptomatic relief of post-operative pain. The SPRINT PNS System is not intended to be placed in the region innervated by the cranial and facial nerves. Physicians should use their best judgment when deciding when to use the SPRINT PNS System. For more information see the SPRINT PNS System IFU. Most common adverse events are skin irritation and erythema. Results may vary. Rx only. 

View references for support of all claims.

Product and brand names/logos are registered or common law trademarks of SPR.

© 2025 SPR. All Rights Reserved.